{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:50:10Z","timestamp":1774543810453,"version":"3.50.1"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Generalized pustular psoriasis (GPP) is a rare, severe inflammatory skin disease marked by widespread sterile pustules on erythematous skin. It poses clinical challenges due to its systemic involvement, unpredictable course and risk of serious complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the clinical features, disease severity, triggers, treatment outcomes and quality of life (QoL) in patients with GPP in India.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A prospective observational study was conducted at a tertiary care hospital in North India from March 2022 to March 2025. Disease severity in patients diagnosed with GPP was determined using the Generalized Pustular Psoriasis Area and Severity Index (GPPASI). We investigated triggers, treatment response, flares and QoL; clinical data, laboratory findings and comorbidities were also analysed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 857 new patients with psoriasis, 46 (5.3%) had GPP [mean age at presentation 36.2\u2005years (SD 16.7), 63% male]. The median inpatient stay was 12\u2005days (interquartile range 7\u201317), and the mean flare count was 3.1 (SD 2.5). Triggers included medications, infections, hypocalcaemia, pregnancy and COVID-19 infection. Mean latency from trigger to flare was 10.4\u2005days (SD 8.5). Systemic inflammation was reflected in laboratory markers. Treatments included acitretin, methotrexate, ciclosporin and biologics, with combination therapy in some patients. Early remission (\u2265 50% GPPASI reduction within 5\u2005days) occurred in 75%, 67% and 65% of patients on biologics, ciclosporin and acitretin, respectively. Sustained remission at 3\u2005months was seen in 60%, 55% and 52% of patients on biologics, ciclosporin and acitretin, respectively. Twelve patients (26%) relapsed, and 6 (13%) had persistent disease. Early responders showed significantly better sustained remission than nonresponders (P = 0.032). Mean (SD) GPPASI scores improved from 25.4 (16.9) on day 1 to 19.1 (13.7) by day 3, with parallel improvement in QoL. There were three deaths; two were COVID-19-related.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In resource-limited settings, early identification of potential triggers and personalized treatment can optimize GPP outcomes. Conventional agents remain effective and affordable alternatives to biologics for shor-term disease control.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ced\/llaf507","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:08:29Z","timestamp":1762952909000},"page":"571-577","source":"Crossref","is-referenced-by-count":0,"title":["A prospective, observational study of the epidemiology, disease characteristics and treatment outcomes of generalized pustular psoriasis in India"],"prefix":"10.1093","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9912-0085","authenticated-orcid":false,"given":"Sunil","family":"Dogra","sequence":"first","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research , Chandigarh ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9495-7502","authenticated-orcid":false,"given":"Apoorva","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research , Chandigarh ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0464-2989","authenticated-orcid":false,"given":"Tarun","family":"Narang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research , Chandigarh ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev","family":"Handa","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research , Chandigarh ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"2026032611534668100_llaf507-B1","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/jdv.14386","article-title":"European consensus statement on phenotypes of pustular psoriasis","volume":"31","author":"Navarini","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026032611534668100_llaf507-B2","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/jamadermatol.2024.0915","article-title":"International consensus definition and diagnostic criteria for generalized pustular psoriasis from the International Psoriasis Council","volume":"160","author":"Choon","year":"2024","journal-title":"JAMA Dermatol"},{"key":"2026032611534668100_llaf507-B3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/14712598.2025.2464858","article-title":"Literature review and expert opinion on diagnosis and current management of generalized pustular psoriasis","volume":"25","author":"Marzano","year":"2025","journal-title":"Expert Opin Biol Ther"},{"key":"2026032611534668100_llaf507-B4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.25259\/IJDVL_219_2024","article-title":"Indian expert Delphi consensus on the diagnosis and management of flares of generalised pustular psoriasis","volume":"91","author":"Aithal","year":"2024","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2026032611534668100_llaf507-B5","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1080\/1744666X.2022.2116003","article-title":"Generalized pustular psoriasis is a disease distinct from psoriasis vulgaris: evidence and expert opinion","volume":"18","author":"Bachelez","year":"2022","journal-title":"Expert Rev Clin Immunol"},{"key":"2026032611534668100_llaf507-B6","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/jdv.18851","article-title":"Generalized pustular psoriasis: a global Delphi consensus on clinical course, diagnosis, treatment goals and disease management","volume":"37","author":"Puig","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026032611534668100_llaf507-B7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/jdv.18720","article-title":"Prevalence, comorbidities and mortality of generalized pustular psoriasis: a literature review","volume":"37","author":"Prinz","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026032611534668100_llaf507-B8","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/CM9.0000000000003494","article-title":"Current status of generalized pustular psoriasis: findings from a multicenter hospital-based survey of 127 Chinese patients","volume":"138","author":"Wang","year":"2025","journal-title":"Chin Med J (Engl)"},{"key":"2026032611534668100_llaf507-B9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1346-8138.1997.tb02779.x","article-title":"Natural history of psoriasis: a study from the Indian subcontinent","volume":"24","author":"Kaur","year":"1997","journal-title":"J Dermatol"},{"key":"2026032611534668100_llaf507-B10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s40257-021-00654-z","article-title":"Clinical course and characteristics of generalized pustular psoriasis","volume":"23","author":"Choon","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"2026032611534668100_llaf507-B11","first-page":"369","article-title":"Burden of skin disease in selective IgA deficiency and common variable immunodeficiency","volume":"25","author":"Gualdi","year":"2015","journal-title":"J Investig Allergol Clin Immunol"},{"key":"2026032611534668100_llaf507-B12","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaad.2022.09.049","article-title":"Comorbidities in patients with generalized pustular psoriasis: a nationwide population-based register study","volume":"88","author":"L\u00f6fvendahl","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"2026032611534668100_llaf507-B13","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/archderm.1991.01680080075005","article-title":"Generalized pustular psoriasis. A review of 63 cases","volume":"127","author":"Zelickson","year":"1991","journal-title":"Arch Dermatol"},{"key":"2026032611534668100_llaf507-B14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/1346-8138.15657","article-title":"Improved quality of life of patients with generalized pustular psoriasis in Japan: a cross-sectional survey","volume":"48","author":"Hayama","year":"2021","journal-title":"J Dermatol"},{"key":"2026032611534668100_llaf507-B15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jdcr.2021.03.024","article-title":"A pustular psoriasis flare treated with calcium supplementation","volume":"12","author":"Masson","year":"2021","journal-title":"JAAD Case Rep"},{"key":"2026032611534668100_llaf507-B16","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jaad.2025.02.018","article-title":"Real-world clinical characteristics and treatment patterns of generalized pustular psoriasis flares","volume":"92","author":"Rhoads","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"2026032611534668100_llaf507-B17","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/bjd\/ljae491","article-title":"Global Delphi consensus on treatment goals for generalized pustular psoriasis","volume":"192","author":"Barker","year":"2025","journal-title":"Br J Dermatol"},{"key":"2026032611534668100_llaf507-B18","doi-asserted-by":"crossref","first-page":"1292941","DOI":"10.3389\/fimmu.2023.1292941","article-title":"The role of the interleukin-36 axis in generalized pustular psoriasis: a review of the mechanism of action of spesolimab","volume":"14","author":"Hawkes","year":"2023","journal-title":"Front Immunol"},{"key":"2026032611534668100_llaf507-B19","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamadermatol.2015.4686","article-title":"Acute generalized pustular psoriasis treated with the IL-17A antibody secukinumab","volume":"152","author":"B\u00f6hner","year":"2016","journal-title":"JAMA Dermatol"},{"key":"2026032611534668100_llaf507-B20","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1080\/14712598.2022.2116978","article-title":"Targeting IL-17A for the treatment of pustular psoriasis: a comprehensive review","volume":"22","author":"Rosi","year":"2022","journal-title":"Expert Opin Biol Ther"},{"key":"2026032611534668100_llaf507-B21","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jamadermatol.2016.0751","article-title":"Therapeutic efficacy of interleukin 12\/interleukin 23 blockade in generalized pustular psoriasis regardless of IL36RN mutation status","volume":"152","author":"Arakawa","year":"2016","journal-title":"JAMA Dermatol"},{"key":"2026032611534668100_llaf507-B22","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.3390\/ijms22052719","article-title":"The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics","volume":"22","author":"Jang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026032611534668100_llaf507-B23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4103\/ijd.IJD_300_18","article-title":"Fixed tapering dosage of acitretin in patients with psoriasis: a short-term analysis of clinical efficacy and its effects on biochemical parameters","volume":"64","author":"Pai","year":"2019","journal-title":"Indian J Dermatol"},{"key":"2026032611534668100_llaf507-B24","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1111\/jdv.14949","article-title":"Generalized pustular psoriasis: a review and update on treatment","volume":"32","author":"Hoegler","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026032611534668100_llaf507-B25","doi-asserted-by":"crossref","first-page":"726","DOI":"10.4103\/ijd.ijd_914_22","article-title":"SARS-CoV-19 and generalised pustular psoriasis: a lethal combination","volume":"68","author":"Narang","year":"2023","journal-title":"Indian J Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llaf507\/65279442\/llaf507.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/4\/571\/65279442\/llaf507.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/4\/571\/65279442\/llaf507.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:53:55Z","timestamp":1774540435000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/51\/4\/571\/8322122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,11,13]]},"published-print":{"date-parts":[[2026,3,26]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llaf507","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2025,11,13]]}}}